U01AI138909
Cooperative Agreement
Overview
Grant Description
Selective CD28 blockade in renal transplant recipients.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Atlanta,
Georgia
30322
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the End Date has been extended from 07/31/23 to 07/31/25 and the total obligations have increased 328% from $1,135,202 to $4,854,457.
Emory University was awarded
Selective CD28 Blockade in Renal Transplant Recipients
Cooperative Agreement U01AI138909
worth $4,854,457
from the National Institute of Allergy and Infectious Diseases in August 2018 with work to be completed primarily in Atlanta Georgia United States.
The grant
has a duration of 7 years and
was awarded through assistance program 93.855 Allergy and Infectious Diseases Research.
The Cooperative Agreement was awarded through grant opportunity NIAID Clinical Trial Implementation Cooperative Agreement (U01).
Status
(Complete)
Last Modified 9/20/24
Period of Performance
8/1/18
Start Date
7/31/25
End Date
Funding Split
$4.9M
Federal Obligation
$0.0
Non-Federal Obligation
$4.9M
Total Obligated
Activity Timeline
Transaction History
Modifications to U01AI138909
Additional Detail
Award ID FAIN
U01AI138909
SAI Number
U01AI138909-1378501495
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75NM00 NIH NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Funding Office
75NM00 NIH NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Awardee UEI
S352L5PJLMP8
Awardee CAGE
2K291
Performance District
GA-05
Senators
Jon Ossoff
Raphael Warnock
Raphael Warnock
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
National Institute of Allergy and Infectious Diseases, National Institutes of Health, Health and Human Services (075-0885) | Health research and training | Grants, subsidies, and contributions (41.0) | $5,939,100 | 100% |
Modified: 9/20/24